MiNK Therapeutics, Inc. reports

Company location: New York, NY
Fiscal year end: 31 December

MiNK Therapeutics, Inc. has filed 253 SEC EDGAR filings since 22 Jan 2021

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 26-50 of 253 matching filings.

Per page

25

Current page

2

EFFECT File 333-291388

EFFECT filing

Filing date: 11 Dec 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 10 Dec 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-3/A File 333-291388

S-3/A

Filing date: 10 Dec 2025
Reporting date: Not listed
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-40908

8-K

Filing date: 08 Dec 2025
Reporting date: 14 Nov 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4

Filing date: 03 Dec 2025
Reporting date: 01 Dec 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 03 Dec 2025
Reporting date: 01 Dec 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 03 Dec 2025
Reporting date: 01 Dec 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 03 Dec 2025
Reporting date: 01 Dec 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 03 Dec 2025
Reporting date: 01 Dec 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 03 Dec 2025
Reporting date: 01 Dec 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-40908

10-Q

Filing date: 14 Nov 2025
Reporting date: 30 Sep 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

S-3 File 333-291388

S-3

Filing date: 07 Nov 2025
Reporting date: Not listed
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4/A

4/A

Filing date: 03 Oct 2025
Reporting date: 09 Sep 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-40908

8-K

Filing date: 29 Sep 2025
Reporting date: 23 Sep 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4

Filing date: 11 Sep 2025
Reporting date: 09 Sep 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 11 Sep 2025
Reporting date: 09 Sep 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 11 Sep 2025
Reporting date: 09 Sep 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 11 Sep 2025
Reporting date: 09 Sep 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 11 Sep 2025
Reporting date: 09 Sep 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 11 Sep 2025
Reporting date: 09 Sep 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 03 Sep 2025
Reporting date: 02 Sep 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 03 Sep 2025
Reporting date: 02 Sep 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 03 Sep 2025
Reporting date: 02 Sep 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 03 Sep 2025
Reporting date: 02 Sep 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 03 Sep 2025
Reporting date: 02 Sep 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .